HDAC9 and urothelial carcinoma: The concentration of 12.5 μM TMP269 was chosen based on recently published data highlighting that >10 μM TMP269 produces strong inhibition of class IIA HDAC enzyme activity in a cell-free system [30] and anti-proliferative effects in, for example, urothelial carcinoma cell lines [51].